Send to a Friend Share

Momenta Pharmaceuticals (MNTA) Replaces HealthSpring (HS) in S&P SmallCap 600

January 30, 2012 7:23 AM EST
MNTA Hot Sheet
Overall Analyst Rating:
    BUY (Up Up)

Revenue Growth %: -69.1%
After the close Friday, S&P announced that Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) will replace HealthSpring, Inc. (NYSE: HS) in the S&P SmallCap 600 index after the close of trading on Tuesday, January 31.

Cigna Corp. (NYSE: CI) is acquiring HealthSpring in a deal expected to be completed on January 30.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Corporate News, Trader Talk

Related Entities

Standard & Poor's

Add Your Comment





Follow StreetInsider.com On Twitter